Gastroenterology

Some gut bacteria can curb atherosclerosis in mice

A recent study provides evidence for the beneficial effects of GMD and the gut commensal bacterium P. merdae against obesity-related atherosclerosis.

Microbiota-derived ethanol may contribute to nonalcoholic fatty liver disease

The findings of a new research suggest that, in some people, microbial ethanol can contribute to the development of NAFLD.

Tumor-microbiota interactions may help to identify new treatments for pancreatic cancer

The findings of a new research may help to develop improved diagnostic or treatment approaches for pancreatic cancer.

L. rhamnosus GG increases Bifidobacteria and reduces inflammation in children with cystic fibrosis, study says

A supplement of LGG would seem to favour the proliferation of Bifidobacterium and the improvement of clinical and immunological response to childhood cystic fibrosis.

How microbiotas interact after fecal transplantation

Researchers found that the microbiota of the recipient, rather than that of the donor, determines the microbial mix resulting from a fecal transplant.

Engraftment levels may determine success of microbiota transplant

The findings of a new research could help to optimize fecal microbiota transplantation (FMT) protocols and identify the most suitable donors for transplantation.

New study demonstrates the positive outcomes of FMT in NAFLD patients

Faecal microbiota transplant appears to effectively improve both clinical parameters and bacterial balance in the liver, especially in thin individuals.

New study supports link between gut bacteria and multiple sclerosis

The findings of a new research shed light on the mechanisms by which gut bacteria influence the development and progression of multiple sclerosis.

High levels of antibodies against specific gut bacteria may be linked to chronic fatigue

The findings of a new research suggest that combining Lachnospiraceae antibody screening with blood tests could improve the diagnosis of ME/CFS.

High-sugar diet could disrupt microbiota, increase odds of obesity and diabetes

The findings of a new study suggest that the interplay between diet, microbiota and intestinal immunity regulates obesity, diabetes and other metabolic conditions.

Subscribe to MicrobiomePost newsletter

Take full advantage of MicrobiomePost‘s features.

Scroll to Top